RIXUBIS
Live / Registered — Registered and renewed (as of 20 Jun 2024)
What this means for you
Registered since 03 Jun 2014. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 03 Jun 2024).
Record
- Serial number
- 85899949
- Registration number
- 4544829
- Mark type
- Stylized text
- Filed
- 10 Apr 2013
- Published for opposition
- 06 Aug 2013
- Registered
- 03 Jun 2014
- Next maintenance due
- 03 Jun 2024
- Attorney of record
- KARL M ZIELAZNICKI
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of hemophilia
Owner
- BAXALTA INCORPORATED, BANNOCKBURN, IL, US
- Baxter International Inc., Deerfield, IL, US
- Baxter International Inc., Deerfield, IL, US
- Baxter International Inc., Deerfield, IL, US
Prosecution history
- 24 Nov 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 Nov 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 Nov 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 Jun 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 20 Jun 2024 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 20 Jun 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 18 Jun 2024 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 15 Jun 2024 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 15 Jun 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 Mar 2024 — TEAS SECTION 8 & 9 RECEIVED
- 03 Jun 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 01 Mar 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 01 Mar 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 01 Mar 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Nov 2020 — TEAS SECTION 8 & 15 RECEIVED